Takeda Taps GSK Executive To Become CEO Next Summer
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals has gone abroad to select its next CEO, GlaxoSmithKline's Christophe Weber, to replace Yasuchika Hasegawa, who plans to step down from the job next summer and become board chairman.